Granahan Investment Management’s Stoke Therapeutics STOK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.04M | Sell |
532,413
-128,017
| -19% | -$1.45M | 0.25% | 92 |
|
|
2025
Q1 | $4.39M | Buy |
660,430
+92,741
| +16% | +$617K | 0.22% | 101 |
|
|
2024
Q4 | $6.26M | Sell |
567,689
-77,281
| -12% | -$852K | 0.26% | 92 |
|
|
2024
Q3 | $7.93M | Buy |
644,970
+46,569
| +8% | +$572K | 0.31% | 96 |
|
|
2024
Q2 | $8.08M | Buy |
598,401
+122,938
| +26% | +$1.66M | 0.32% | 89 |
|
|
2024
Q1 | $6.42M | Sell |
475,463
-662,424
| -58% | -$8.94M | 0.23% | 115 |
|
|
2023
Q4 | $5.99M | Buy |
1,137,887
+286,686
| +34% | +$1.51M | 0.2% | 122 |
|
|
2023
Q3 | $3.35M | Buy |
851,201
+318,321
| +60% | +$1.25M | 0.12% | 143 |
|
|
2023
Q2 | $5.66M | Sell |
532,880
-70,644
| -12% | -$751K | 0.17% | 127 |
|
|
2023
Q1 | $5.03M | Buy |
603,524
+53,305
| +10% | +$444K | 0.15% | 125 |
|
|
2022
Q4 | $5.08M | Buy |
550,219
+291,205
| +112% | +$2.69M | 0.16% | 129 |
|
|
2022
Q3 | $3.33M | Buy |
259,014
+60,393
| +30% | +$776K | 0.11% | 146 |
|
|
2022
Q2 | $2.62M | Buy |
+198,621
| New | +$2.62M | 0.09% | 152 |
|